ERBB2 and breast cancer: EV-bound proteins have been demonstrated to play important roles in critical processes for BC progression and metastasis, including tumor vascularization21,22, HER2-targeted therapy resistance23, matrix remodeling24, immune evasion25, and premetastatic niche formation26,27.